Remel "ready" for IVDD (In Vitro Diagnostics Directive) deadline with ISO successes
This article was originally published in Clinica
Executive Summary
Remel Europe says it is well on its way to meeting the new CE-marking requirements of the In Vitro Diagnostics Directive (IVDD), after obtaining ISO 9001-2000 accreditation within three months of becoming fully operational, the company announced yesterday (October 8 2003). The standard is a precondition for CE-marking all diagnostic tests under the IVDD, for which the deadline for transposition into national law is December 7 2003.
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.